Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [3H]CP55940 and [3H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release

European Journal of Pharmacology

Volumn 723, Issue 1, 2014, Pages 431-441

  Dhopeshwarkar, Amey Sadashiv ^a,b   Nicholson, Russell Alfred ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b INDIANA UNIVERSITY   (United States)

Author keywords

(S) methoprene; ; Benzophenanthridine alkaloid; CB1 receptor; Piperonyl butoxide

Indexed keywords

(S)-METHOPRENE; 4-AP; BENZOPHENANTHRIDINE ALKALOID; CB1 RECEPTOR; L-GLUTAMATE; PIPERONYL BUTOXIDE; SYNAPTOSOME; [35S]GTPΓS; [3H]CP55940; [3H]SR141716A;

ANIMALS; BENZOPHENANTHRIDINES; BENZOXAZINES; BINDING SITES; BRAIN; CYCLOHEXANOLS; GLUTAMIC ACID; ISOQUINOLINES; MALE; METHOPRENE; MICE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PIPERONYL BUTOXIDE; PYRAZOLES; RADIOLIGAND ASSAY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPLEEN; SYNAPTOSOMES;

EID: 84893762515     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.059     Document Type: Article

References (56)

1. M. Bari, T. Bonifacino, M. Milanese, S. Spagnuolo, S. Zappettini, N. Battista, F. Giribaldi, C. Usai, G. Bonanno, and M. Maccarrone The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release Cell. Mol. Life Sci. 68 1 2011 833 845
2. E. Beausoleil, C. Chauvignac, T. Taverne, S. Lacombe, L. Pognante, B. Leblond, D. Pallares, C. De Oliveira, F. Bachelot, R. Carton, H. Peillon, S. Coutadeur, V. Picard, N. Lambeng, L. Desire, and F. Schweighoffer Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding Biorgan. Med. Chem. Lett. 19 1 2009 5594 5598
3. 1) receptor of mammalian brain: Inhibition by phthalate esters in vitro Neurochem. Int. 59 5 2011 706 713
4. H. Bradshaw, and J. Walker The expanding field of cannabimimetic and related lipid mediators Br. J. Pharmacol. 144 1 2005 459 465 (Pubitemid 40349453)
5. V. Chevaleyre, K. Takahashi, and P. Castillo Endocannabinoid-mediated synaptic plasticity in the CNS 29 1 2006 37 76 Annu. Rev. Neurosci. 29 1 2006 37 76
6. S. Childers, and S. Deadwyler Role of cyclic AMP in the actions of cannabinoid receptors Biochem. Pharmacol. 52 1 1996 819 827 (Pubitemid 26301881)
7. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G. Gessa Appetite suppression and weight loss after the cannabinoid antagonists SR141716 Life Sci. 63 8 1998 113 117 (Pubitemid 28378339)
8. 9-tetrahydrocannabinol J. Exp. Ther. 263 1 1992 1118 1126 (Pubitemid 23157189)
9. S. Deadwyler, R. Hampson, B. Bennett, T. Edwards, J. Mu, M. Pacheco, S. Ward, and S. Childers Cannabinoids modulate potassium current in cultured hippocampal neurons Recept. Channels 1 1 1993 121 134
10. W. Devane, F. Dysarz, M. Johnson, L. Melvin, and A. Howlett Determination and characterization of a cannabinoid receptor in rat-brain Mol. Pharmacol. 34 5 1988 605 613 (Pubitemid 19007296)
11. A. Dhopeshwarkar, S. Jain, C. Liao, S. Ghose, K. Bisset, and R. Nicholson The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB1 receptor in vitro Eur. J. Pharmacol. 654 1 2011 26 32
12. V. Di Marzo The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation Pharmacol. Res. 60 1 2009 77 84
13. P. Dunkley, P. Jarvie, and P. Robinson A rapid percoll gradient procedure for preparation of synaptosomes Nat. Protoc. 3 11 2008 1718 1728
14. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 3 2003 1017 1066 (Pubitemid 36828930)
15. S. Gatley, R. Lan., B. Pyatt, A. Gifford, N. Volkow, and A. Makriyannis Binding of the non-classical cannabinoid CP55940 and the diarylpyrazole AM251 to rodent brain cannabinoid receptors Life Sci. 61 14 1997 191 197
16. 2+ influx and glutamate release through two different mechanisms active in distinct populations of cerebrocortical nerve terminals J. Neurochem. 101 6 2007 1471 1482 (Pubitemid 46848838)
17. 1 cannabinoid receptors heterologously expressed in mammalian neurons Mol. Pharmacol. 65 3 2004 665 674 (Pubitemid 38264034)
18. M. Herkenham, A. Lynn, M. Johnson, L. Melvin, B. Decosta, and K. Rice Characterization and localization of cannabinoid receptors in rat-brain -a quantitative in vitro autoradiographic study J. Neurosci. 11 2 1991 563 583
19. 1) J. Pharmacol. Exp. Ther. 289 3 1999 1427 1433 (Pubitemid 29246674)
20. D. Houston, and A. Howlett Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins Mol. Pharmacol. 43 1 1993 17 22 (Pubitemid 23027643)
21. A. Howlett Cannabinoid inhibition of adenylate-cyclase biochemistry of the response in neuroblastoma cell membranes Mol. Pharmacol. 27 4 1985 429 436 (Pubitemid 15088930)
22. A. Howlett, F. Barth, T. Bonner, G. Cabral, P. Casellas, W. Devane, C. Felder, M. Herkenham, K. Mackie, B. Martin, R. Mechoulam, and R. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2 2002 161 202 (Pubitemid 34575709)
23. A. Howlett, and R. Fleming Cannabinoid inhibition of adenylate-cyclase: pharmacology of the response in neuroblastoma cell membranes Mol. Pharmacol. 26 3 1984 532 538 (Pubitemid 15190717)
24. i in the inhibition of adenylate-cyclase by cannabimimetic drugs Mol. Pharmacol. 29 3 1986 307 313 (Pubitemid 16137598)
25. L. Iversen Cannabis and the brain Brain 126 1 2003 1252 1270 (Pubitemid 36644373)
26. M. Johnson, and L. Melvin The discovery of nonclassical cannabinoid analgetics in Cannabinoids as Therapeutic Agents R. Mechoulam, 1986 CRC Boca Raton, FL 121 145
27. 1 transmembrane helix 7 Mol. Pharmacol. 71 6 2007 1512 1524 (Pubitemid 47010904)
28. 1 cannabinoid receptors regulate GABA release form axon terminals of specific hippocampal interneurons J.Neurosci. 19 1 1999 4555 4558
29. 1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum J.Neurosci. 26 11 2006 2991 3001
30. + currents in rat dorsal root ganglion neurons Brain Res. 1062 1 2005 39 47 (Pubitemid 41612127)
31. A. Kreitzer, and W. Regehr Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells Neuron 29 3 2001 717 727 (Pubitemid 32323944)
32. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a Calyx synapse J. Neurosci. 24 1 2004 5955 5965 (Pubitemid 38859393)
33. R. Lan, Q. Liu, P. Fan, S. Lin, S. Fernando, D. McCallion, R. Pertwee, and A. Makriyannis Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists J. Med. Chem. 42 4 1999 769 776 (Pubitemid 29110792)
34. C. Liao, J. Zheng, L. David, and R. Nicholson Inhibition of voltage-sensitive sodium channels by the cannabinoid-1 receptor antagonist AM251 in mammalian brain Basic Clin. Pharmacol. Toxicol. 94 2 2004 73 78 (Pubitemid 41709875)
35. A. Ligresti, S. Petrosino, and V. Di Marzo From endocannabinoid profiling to 'endocannabinoid therapeutics' Curr. Opin. Chem. Biol. 13 1 2009 321 331
36. K. Mackie, and B. Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma glioma-cells Proc. Natl. Acad. Sci. USA 89 9 1992 3825 3829
37. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in ATT20 cells transfected with rat-brain cannabinoid receptor J. Neurosci. 15 10 1995 6552 6561
38. D. Nicholls, T. Sihra, and J. Sanchez-prieto Calcium-dependent and calcium-independent release of glutamate from synaptosomes monitored by continuous fluorometry J. Neurochem. 49 1 1987 50 57
39. R. Nicholson, C. Liao, J. Zheng, L. David, L. Coyne, A. Errington, G. Singh, and G. Lees Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain Brain Res. 978 1-2 2003 194 204 (Pubitemid 36776639)
40. G. Peterson Simplification of protein assay method of Lowry et al., which is more generally applicable Anal. Biochem. 83 2 1977 346 356 (Pubitemid 8269786)
41. R. Razdan Structure-activity-relationships in cannabinoids Pharmacol. Rev. 38 2 1986 75 149
42. G. Riedel, P. Fadda, S. McKillop-Smith, R.G. Pertwee, B. Platt, and L. Robinson Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice Br. J. Pharmacol. 156 1 2009 1154 1166
43. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie, C. Breliere, and G. Lefur SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett. 350 2-3 1994 240 244 (Pubitemid 24268029)
44. 1) cannabinoid receptor antagonist, in rodent brain Life Sci. 58 1 1996 1239 1247 (Pubitemid 26096331)
45. 1 receptor for drug discovery Curr. Top. Med. Chem. 10 1 2010 779 798
46. M. Steffens, C. Engler, J. Zentner, and T. Feuerstein Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex Br. J. Pharmacol. 141 7 2004 1193 1203 (Pubitemid 38582257)
47. S. Stigliani, S. Zappettini, L. Raiteri, M. Passalacqua, E. Melloni, C. Venturi, C. Tacchetti, A. Diaspro, C. Usai, and G. Bonanno Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate J. Neurochem. 96 1 2006 656 668
48. G. Szabo, B. Varga, D. Payer-Lengyel, A. Szemzo, P. Erdelyi, K. Vukics, J. Szikra, E. Hegyi, M. Vastag, B. Kiss, J. Laszy, I. Gyertyn, and J. Fischer Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists J. Med. Chem. 52 1 2009 4329 4337
49. 2 receptor antagonist Br. J. Pharmacol. 146 1 2005 917 926 (Pubitemid 41722163)
50. 1 receptors in the rat central nervous system Neuroscience 83 1 1998 393 411 (Pubitemid 28062631)
51. W. Twitchell, S. Brown, and K. Mackie Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons J. Neurophys. 78 1 1997 43 50 (Pubitemid 27318909)
52. 1 receptors in the brainstem of the ferret Gastroenterology 121 4 2001 767 774 (Pubitemid 32959386)
53. 1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes Eur. J. Pharmacol. 469 1-3 2003 47 55 (Pubitemid 36629549)
54. R. Wilson, and R. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 6828 2001 588 592 (Pubitemid 32267203)
55. C. Wu, M. Hung, J. Song, T. Yeh, M. Chou, C. Chu, J. Jan, M. Hsieh, S. Tseng, C. Chang, W. Hsieh, Y. Lin, Y. Yeh, W. Chung, C. Kuo, C. Lin, H. Shy, Y. Chao, and K. Shia Discovery of 2-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4- ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydroimidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice J. Med. Chem. 52 1 2009 4496 4510
56. F. Zádor, F. Otvös, S. Benyhe, A. Zimmer, and E. Páldy Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors Neurochem. Int. 61 3 2012 378 388